Veno T&R Succeeds in Attracting 10 Billion Won Investment... Forecasts 'Change in Largest Shareholder' via Third-Party Allotment Capital Increase

KOSDAQ-listed company Veno T&R (CEO Jung Jip-hoon) announced on the 3rd that it has decided on a third-party allotment paid-in capital increase of approximately 10 billion won.

The new shares to be issued through this capital increase are 11,737,089 common shares, and the issue price per share is 852 won, a 10% discount from the base share price of 946 won. The total amount of funds to be raised through the capital increase is 9,999,999,828 won (approximately 10 billion won), which will be used in full as operating funds, such as operating expenses required for company operations. The estimated amount to be used by year is 3 billion won in 2027 and 7 billion won from 2028 onwards.

The target for the third-party allotment is 'Acro New Technology Fund No. 241'. Regarding the background of selecting the target, the company stated, "We made the final selection by considering the investor's intention, payment ability, and timing to achieve the company's management objectives and secure swift funding." Meanwhile, the remarks section for this target included details of a stock transfer agreement entailing a change in the largest shareholder.

The payment date for the paid-in capital increase is December 23, 2026, and the expected listing date for the new shares is January 11, 2027. All new shares issued through this paid-in capital increase will be subject to a one-year lock-up at the Korea Securities Depository.